Boston Scientific Announces Results for Second Quarter 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Boston Scientific (BSX) PT Raised to $32 at Cowen
July 27, 2017 3:50 PM EDTCowen raised its price target on Boston Scientific (NYSE: BSX) to $32.00 (from $31.00) while maintaining a Outperform rating.
Management revised full year 2017 guidance and effectively kept the midpoint of the organic revenue guidance range intact at 5.8% while raising the EPS target by $0.01.
... MoreStifel Reiterates Buy on Boston Scientific (BSX) Following 2Q
July 27, 2017 1:41 PM EDTStifel reiterated a Buy rating and $32.00 price target on Boston Scientific (NYSE: BSX) following the company's 2Q. Revenue at $2.257 billion grew 6% reported and on organic basis, and 7% on an operational basis. BSX modestly raised the top-end of its previous 2017 organic sales growth... More



